Calik-Ksepka Anna, Grymowicz Monika, Rudnicka Ewa, Skórska Jolanta, Machura Paulina, Pięta Wojciech, Smolarczyk Roman
Department of Gynaecological Endocrinology, Medical University of Warsaw, Warsaw, Poland.
Prz Menopauzalny. 2018 Sep;17(3):131-134. doi: 10.5114/pm.2018.78558. Epub 2018 Sep 30.
Premature ovarian insufficiency (POI) occurs in 1% of women under 40 years old. Hypoestrogenism associated with this condition may result in vaginal atrophy and urine incontinence, called genitourinary syndrome. The symptoms include: vaginal dryness, irritation, dyspareunia, and dysuria. There is relative lack of studies on the occurrence and treatment of genitourinary problems in women with POI. Prevalence rates vary from 17 to 54% depending on cause, duration of oestrogen depletion, and the treatment used. Patients with POI gain lower scores in tests measuring vaginal health or sexual function in comparison to healthy peers. Hormonal treatment in premature ovarian insufficiency is recommended until the natural age of menopause. The vaginal route of oestrogen administration is supposed to be the criterion standard in treating genitourinary symptoms. Androgen supplementation is not routinely recommended.
卵巢早衰(POI)发生在1%的40岁以下女性中。与这种情况相关的雌激素缺乏可能导致阴道萎缩和尿失禁,称为生殖泌尿综合征。症状包括:阴道干燥、刺激、性交困难和排尿困难。关于POI女性生殖泌尿问题的发生和治疗的研究相对较少。患病率因病因、雌激素缺乏持续时间和所用治疗方法而异,从17%到54%不等。与健康同龄人相比,POI患者在测量阴道健康或性功能的测试中得分较低。建议对卵巢早衰患者进行激素治疗,直至自然绝经年龄。雌激素经阴道给药途径被认为是治疗生殖泌尿症状的标准方法。一般不建议常规补充雄激素。